See a video of Bob’s story 56k | 300k >>

To read more Personal Success Stories, subscribe to our newsletter >>

To learn more about Cardiac Resynchronization Therapy, request more information >>

This story recounts the experiences of patients who are receiving Cardiac Resynchronization Therapy for moderate to severe heart failure with ventricular dysynchrony. Medtronic, Inc. invited them to share their story candidly. As you read it, please bear in mind that these experiences are specific to these particular patients. Results vary; not every response is the same.

Information on this website should not be a substitute for consulting with your physician.

The InSync®, InSync ICD®, and InSync® III Cardiac Resynchronization Therapy systems were studied in the United States in patients with moderate to severe heart failure (Class III and IV), limited functional capacity, systolic ventricular dysfunction, and ventricular dysynchrony. Please consult with your physician to determine if you are a candidate. As with any active implantable device, there are potential risks associated with the InSync systems. In the U.S. clinical study investigating the InSync system, some patients reported worsening heart failure that required additional treatment. Some patients experienced loss of cardiac resynchronization because of lead dislodgement or other lead related events. Other patients reported irregular heartbeats (arrhythmias) that were treated by implanting a cardioverter defibrillator (ICD) or drug therapy. Your physician should discuss these and other potential risks with you.

Important Safety Information